Search
Envista Holdings Corp
NVSTAdd to Watchlist
25.255USD
-0.255-1.00%
Close 06/23, 16:00（ET）Quotes delayed by 15 min
4.11BMarket Cap
61.38P/E TTM
View Detailed Chart
TradingKey 图表Intraday
1m
30m
1h
D
W
M
D
Today
-1.00%
5 Days
+2.04%
1 Month
+7.79%
6 Months
+15.48%
Year to Date
+16.33%
1 Year
+33.62%
Key Figures
25.290Open
25.665High
1.93MVolume
61.38P/E TTM
16.15P/E Dynamic
--Dividend TTM
1.17%Turnover Ratio
25.510Prev. Close
25.180Low
27.12MTurnover
LossP/E Static
1.35P/B
0.00%Div Yield TTM
1.23%ROA
30.42052wk High
0.69Volume Ratio
-1.12BNet Profit
165.00MShares
0.4115EPS TTM
0.90Beta
2.21%ROE
17.78052wk Low
1.90%Amplitude
55.73%Gross Margin
4.11BMarket Cap
4.27Reward/Risk
2.08%Risk Rate
TradingKey Stock Score of Envista Holdings Corp
Currency: USD Updated: 2026-06-23Key Insights
Envista Holdings Corp's fundamentals are relatively very healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 24 out of 204 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 29.75.In the medium term, the stock price is expected to remain stable.The company has been performing well in the stock market over the past month, which is supported by its strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Envista Holdings Corp's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Neutral
Envista Holdings Corp Highlights
StrengthsRisks
Envista Holdings Corporation is a global dental products company. The Company's diversified portfolio of solutions covers a range of dentists' clinical needs for preventing, diagnosing, and treating dental conditions as well as improving the aesthetics of the human smile. It has more than 30 dental brands, including Nobel Biocare, Ormco, DEXIS and Kerr. Its segments include Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment primarily develops, manufactures and markets dental implant systems, including regenerative solutions, dental prosthetics and associated treatment software and technologies, as well as orthodontic bracket systems, aligners and lab products. The Equipment & Consumables segment primarily develops, manufactures, and markets dental equipment and supplies used in dental offices, including digital imaging systems, software, and other visualization/magnification systems; and endodontic systems and related products.
Turnaround to Profit
The company's performance has turned profitable, with the latest annual net income of USD .
Overvalued
The company’s latest PE is 61.39, at a high 3-year percentile range.
Institutional Selling
The latest institutional holdings are 203.45M shares, decreasing 1.59% quarter-over-quarter.
Held by John Rogers
Star Investor John Rogers holds 11.82M shares of this stock.
Analyst Rating
Based on
15
analysts
Buy
Current Rating
29.750
Target Price
+16.62%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Envista Holdings Corp News
More news coming soon, stay tuned...
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Envista Holdings Corp Info
Envista Holdings Corporation is a global dental products company. The Company's diversified portfolio of solutions covers a range of dentists' clinical needs for preventing, diagnosing, and treating dental conditions as well as improving the aesthetics of the human smile. It has more than 30 dental brands, including Nobel Biocare, Ormco, DEXIS and Kerr. Its segments include Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment primarily develops, manufactures and markets dental implant systems, including regenerative solutions, dental prosthetics and associated treatment software and technologies, as well as orthodontic bracket systems, aligners and lab products. The Equipment & Consumables segment primarily develops, manufactures, and markets dental equipment and supplies used in dental offices, including digital imaging systems, software, and other visualization/magnification systems; and endodontic systems and related products.
Ticker SymbolNVST
CompanyEnvista Holdings Corp
CEOKeel (Paul A)
Websitehttps://envistaco.com/en
Related Instruments
+0.65%
+1.10%
+3.05%
+0.06%
+0.27%
+0.47%
+1.74%
+1.70%
+2.64%
+0.11%
+0.37%
+2.82%
+3.61%
+1.26%
+1.70%
-0.42%
-0.86%
+2.30%
+0.11%
-0.23%Popular Instruments
71.469
-1.476 (-2.02%)
294.300
-2.710 (-0.91%)
200.040
-8.610 (-4.13%)
4044.080
-66.670 (-1.62%)
670.750
-61.870 (-8.45%)
1961.070
-312.660 (-13.75%)
1051.770
-159.610 (-13.18%)
346.130
-3.550 (-1.02%)
62369.970
-70.730 (-0.11%)
381.610
-23.440 (-5.79%)
FAQs
What is the current price of Envista Holdings Corp (NVST)?
The current price of Envista Holdings Corp (NVST) is 25.25.
What is the symbol of Envista Holdings Corp?
The ticker symbol of Envista Holdings Corp is NVST.
What is the 52-week high of Envista Holdings Corp?
The 52-week high of Envista Holdings Corp is 30.42.
What is the 52-week low of Envista Holdings Corp?
The 52-week low of Envista Holdings Corp is 17.78.
What is the market capitalization of Envista Holdings Corp?
The market capitalization of Envista Holdings Corp is 4.11B.
Is Envista Holdings Corp (NVST) currently rated as Buy, Hold, or Sell?
According to analysts, Envista Holdings Corp (NVST) has an overall rating of Buy, with a price target of 29.75.
What is the Earnings Per Share (EPS TTM) of Envista Holdings Corp (NVST)?
The Earnings Per Share (EPS TTM) of Envista Holdings Corp (NVST) is 0.28.
